<DOC>
	<DOCNO>NCT00004200</DOCNO>
	<brief_summary>RATIONALE : Prinomastat may stop growth glioblastoma multiforme stop blood flow tumor . Drugs use chemotherapy stop tumor cell divide stop grow die . PURPOSE : Randomized phase II trial study effectiveness prinomastat plus temozolomide treating patient newly diagnose glioblastoma multiforme .</brief_summary>
	<brief_title>Prinomastat Plus Temozolomide Following Radiation Therapy Treating Patients With Newly Diagnosed Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : I . Compare one year survival rate progression free survival patient newly diagnose glioblastoma multiforme treat prinomastat ( AG3340 ) placebo temozolomide follow radiotherapy . II . Compare safety regimens patient . III . Compare quality life patient regimens . OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients receive oral prinomastat placebo twice daily combination oral temozolomide daily day 1-5 . Treatment repeat every 28 day absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : Approximately 100 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Prinomastat</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose glioblastoma multiforme Must complete appropriate subtotal total surgical procedure ( surgical biopsy alone eligible ) Must receive prior external beam radiotherapy No multifocal glioblastoma multiforme No radiographic disease progression post surgical radiotherapy PATIENT CHARACTERISTICS : Age : 16 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Stable steroid therapy least 2 week prior study Radiotherapy : See Disease Characteristics No prior interstitial brachytherapy radiosurgery Surgery : See Disease Characteristics No prior radiosurgery</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>